ANKRD1 and prostate carcinoma: Jimenez et al. found that ANKRD1 is inactivated by DNA methylation in several tumor cell lines, including A427 (lung cancer), LNCaP (prostate cancer), MCF7 (breast cancer), and MeWo (skin cancer)16.